At a Glance

Your Trusted CDMO Partner

  • Global Clients

    100+

  • Employees

    4,400+

  • Global Regulatory
    Approvals

  • Total Capacity

    604KL + Plant 5 *

    Plant 1

    30,000L

    Plant 2

    154,000L

    Plant 3

    180,000L

    Plant 4

    240,000L

    Plant 5

    180,000L*

    * To be operational in April 2025

Awards

By consistently delivering superior client satisfaction through execution excellence and innovation, Samsung Biologics has been selected by our clients for the CDMO Leadership Awards for ten consecutive years.

CDMO LEADERSHIP AWARDS 2023 image
CDMO LEADERSHIP AWARDS 2023 image
Samsung Biologics received additional
recognition as “Champion” in the
Capabilities, Compatibility, Quality, and
Reliability categories
CDMO LEADERSHIP AWARDS 2023 image

Global Regulatory Approvals

Global Regulatory Approvals Detail
Number of Approvals 2015 2016 2017 2018 2019 2020 2021 2022 2023
FDA 1 3 4 8 9 15 18 25 30
EMA 4 5 7 12 15 19 25 32
Others
(PMDA, MFDS, and etc.)
4 8 37 63 100 153 206
Cumulative Total 1 7 13 23 58 93 137 203 268
  • FDA FDA
  • EUROPEAN MEDICINES AGENCY EUROPEAN MEDICINES AGENCY
  • Pmda Pmda
  • Public Health Agency of Canada Public Health Agency of Canada
  • Cofepris Cofepris
  • republic of turkey ministry of health republic of turkey ministry of health
  • ANVISA ANVISA
  • Ministry of Health and Welfare Ministry of Health and Welfare
  • SID & GP SID & GP

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy
close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION